Shares of Roche Holding AG (OTCMKTS:RHHBY – Get Free Report) have received a consensus rating of “Hold” from the eight research firms that are currently covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating, one has given a buy rating and two have issued a strong buy rating on the company.
A number of research firms have commented on RHHBY. Morgan Stanley began coverage on Roche in a research note on Wednesday, February 12th. They set an “equal weight” rating on the stock. Sanford C. Bernstein upgraded Roche to a “strong-buy” rating in a research note on Thursday, January 30th. HSBC lowered Roche from a “buy” rating to a “hold” rating in a research note on Monday. UBS Group upgraded Roche from a “hold” rating to a “strong-buy” rating in a research note on Thursday, February 13th. Finally, Hsbc Global Res lowered Roche from a “strong-buy” rating to a “hold” rating in a research note on Monday.
Check Out Our Latest Stock Analysis on Roche
Hedge Funds Weigh In On Roche
Roche Price Performance
RHHBY opened at $40.77 on Monday. The business has a 50 day moving average of $40.73 and a 200-day moving average of $38.62. The company has a quick ratio of 0.97, a current ratio of 1.26 and a debt-to-equity ratio of 0.86. Roche has a 12-month low of $29.20 and a 12-month high of $44.31.
About Roche
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.
See Also
- Five stocks we like better than Roche
- What is the MACD Indicator and How to Use it in Your Trading
- Why D-Wave’s Project With Davidson Is a Game-Changer For Quantum
- Dividend Capture Strategy: What You Need to Know
- Hims & Hers Stock Soars on Novo Nordisk Collaboration
- Dividend Payout Ratio Calculator
- Amazon’s Earnings Will Make or Break the Stock’s Comeback
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.